Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck's (MRK) Keytruda Gets Four New Approvals in Japan
05:47pm, Wednesday, 28'th Sep 2022 Zacks Investment Research
The Ministry of Health, Labour and Welfare approves Merck's (MRK) anti-PD-1 therapy, Keytruda, for four new cancer indications in Japan.
Merck's (MRK) Keytruda Gets Four New Approvals in Japan
03:03pm, Wednesday, 28'th Sep 2022
The Ministry of Health, Labour and Welfare approves Merck's (MRK) anti-PD-1 therapy, Keytruda, for four new cancer indications in Japan.
Bear Market: 2 Safe Stocks to Buy Right Now
02:45pm, Wednesday, 28'th Sep 2022 The Motley Fool
These businesses might be slightly "boring," but that may just be a good thing in today's market.
Bear Market: 2 Safe Stocks to Buy Right Now
10:45am, Wednesday, 28'th Sep 2022
These businesses might be slightly "boring," but that may just be a good thing in today's market.
Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?
10:20am, Wednesday, 28'th Sep 2022 Zacks Investment Research
Style Box ETF report for DJD
7 Blue-Chip Sleeper Stocks to Buy Before Wall Street Wakes Up
06:00am, Wednesday, 28'th Sep 2022
It may not occur to investors to look for blue-chip sleeper stocks, since they don't often think of blue-chips as “sleepers.” In tough times, seasoned investors seek comfort in the stability and s
Merck (MRK) Dips More Than Broader Markets: What You Should Know
09:45pm, Tuesday, 27'th Sep 2022 Zacks Investment Research
Merck (MRK) closed the most recent trading day at $85.84, moving -0.39% from the previous trading session.
Virtus' Joe Terranova offers his volatility playbook
05:22pm, Tuesday, 27'th Sep 2022
Joe Terranova, Virtus Investment Partners chief market strategist, joins 'Closing Bell: Overtime' to discuss CNBC's Alpha Survey results and where he's looking in the market now.
Atea (AVIR) Dengue Candidate Gets Fast Track Designation
01:53pm, Tuesday, 27'th Sep 2022 Zacks Investment Research
Atea Pharmaceuticals (AVIR) obtains Fast Track Designation in the United States for AT-752 for the treatment of dengue virus infection.
7 Dow Sleeper Stocks to Buy Before Wall Street Wakes Up
04:22pm, Monday, 26'th Sep 2022
While investors might not desire anything less than the most exciting investment opportunities following the wild ride last year, 2022 may be the moment for Dow sleeper stocks to buy. After all, the c
Good Stocks To Buy Right Now? 4 Healthcare Stocks To Know
03:06pm, Monday, 26'th Sep 2022
4 top healthcare stocks for your second-half of 2022 watchlist.
Dow Jones ETF Avoids Bear Market: 4 Stocks in Green
02:30pm, Monday, 26'th Sep 2022 Zacks Investment Research
Both the S&P 500 and the tech-heavy Nasdaq Index are in bear market while the Dow Jones in the only of the three main indexes not to have bear market status.
Dow Jones ETF Avoids Bear Market: 4 Stocks in Green
12:02pm, Monday, 26'th Sep 2022
Both the S&P 500 and the tech-heavy Nasdaq Index are in bear market while the Dow Jones in the only of the three main indexes not to have bear market status.
Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2022 Update
05:04am, Monday, 26'th Sep 2022 Seeking Alpha
Jeremy Grantham’s 13F portfolio value decreased from $20.73B to $18.46B this quarter. Click to read more about GMO Capital's holdings and trades for Q2 2022.
Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris
12:47pm, Friday, 23'rd Sep 2022
Merck (MRK) gets a favorable ruling from a district court of West Virginia in two patents related to Januvia/Janumet against Viatris, which is looking to market its generic versions of the medicines i
